RetroNose

RetroNose™

RetroNose™: the pMDI concept device targeting nasal drug delivery through oral administration

TECHNICAL FEATURES

  • pMDI concept technology with an adapted mouthpiece and innovative trigger mechanism
  • Nasal drug delivery through buccal aerosol administration
  • Spray triggering upon positive pressure in the buccal cavity during nasal expiratory phase
  • Better treatment efficacy with lower drug amount* thanks to a fairly
    homogeneous deposition in the nasal cavities
  • Low variability in terms of deposition distribution vs nasal pumps
  • Opportunity of treating nose and throat in one-go
  • Reduced patient-to-patient variability by avoiding the nasal valve passage
RetroNose: the pMDI concept device targeting nasal drug delivery through oral administration

* To be verified with a clinical trial

Article-PharmaPost-innovation-nasal-delivery

Article “The very promising nasal route"

'The Pharmaceutical Post' magazine - Jan 2020

Article-ODD-RetroNose-Three-nasal-cast-models

Article “Deposition in three nasal cast models using RetroNose Concept"

'Pulmonary and Nasal delivery’ magazine - April 2019

Article-ODD-RetroNose-Nasal-delivery-via-PMDI

Article “Nasal drug delivery via the oral route using a pMDI"

'Pulmonary and Nasal Delivery' magazine - Nov 2018